The LCH Steering Committee is responsible for charting strategic direction of the HS in their specified areas, including conduct of clinical trials and engagement with the broader group of investigators interested in LCH. 

Current members of the LCH Steering Committee include:

Matthew Collin - Co-Chair
Newcastle University, Newcastle upon Tyne, United Kingdom
Term of Office: 2020 - 2024

Olga Slater - Co-Chair
Great Ormond Street Hospital for Children - London, UK
Term of Office: 2022 - 2026

Oussama Abla
Hospital for Sick Children - Toronto, ON Canada
Term of Office: 2025 - 2029

Karin Beutel
Kinderklinik Munchen-Schwabing – Munich, Germany
Term of Office: 2021 - 2025

Ilia Buhtaroiov
Cleveland Clinic - Cleveland, OH USA
Term of Office: 2025 - 2029

Patrick Campbell
St. Jude Children's Research Hospital - Memphis, TN USA
Term of Office: 2022 - 2026

Olive Eckstein
Texas Children's Hospital - Houston, TX USA
Term of Office: 2025 - 2029

Dmitri Evseev
Kepler University Clinic - Linz, Austria
Term of Office: 2025 - 2029

 

Mark Fluchel 
Seattle Children's Hospital - Seattle, WA USA
Term of Office: 2022 - 2026

Nitya Gulati
Weill Cornell Medicine - New York, NY USA
Term of Office: 2025 - 2029

Ashish Kumar
Cincinnati Children's Research Hospital - Cincinnatti, OH USA
Term of Office: 2022 - 2026

Diego Rosso
Hospital de Niños Dr P Elizalde – Buenos Aires, Argentina
Term of Office: 2022 - 2026

Yoko Shiodo
National Center for Child Health & Development - Tokyo, Japan
Term of Office: 2025 - 2029

Karel Svojgr
University Hospital Motol - Prague, Czech Republic
Term of Office: 2025 - 2029

Rui Zhang
Beijing Children's Hospital - Beijing, China
Term of Office: 2022 - 2026

 

 
 
 
332 N Broadway | Pitman, NJ 08071 USA
+1 (856) 589-6606 | secretariat@histiocytesociety.org
2026 Histiocyte Society.
All Rights Reserved.